Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

Cancer Research
Hillary G CarusoLaurence J N Cooper

Abstract

Many tumors overexpress tumor-associated antigens relative to normal tissue, such as EGFR. This limits targeting by human T cells modified to express chimeric antigen receptors (CAR) due to potential for deleterious recognition of normal cells. We sought to generate CAR(+) T cells capable of distinguishing malignant from normal cells based on the disparate density of EGFR expression by generating two CARs from monoclonal antibodies that differ in affinity. T cells with low-affinity nimotuzumab-CAR selectively targeted cells overexpressing EGFR, but exhibited diminished effector function as the density of EGFR decreased. In contrast, the activation of T cells bearing high-affinity cetuximab-CAR was not affected by the density of EGFR. In summary, we describe the generation of CARs able to tune T-cell activity to the level of EGFR expression in which a CAR with reduced affinity enabled T cells to distinguish malignant from nonmalignant cells.

References

Dec 28, 1994·Journal of Immunological Methods·L KarawajewK Ganzel
Feb 17, 1997·The Journal of Experimental Medicine·Z CaiJ Sprent
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonM E Harper
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M Kelly NicholasRavi Salgia
Mar 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Megan M SuhoskiCarl H June
Apr 17, 2008·Cancer Research·Harjeet SinghLaurence J N Cooper
Apr 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Christopher C GovernEric S Huseby
Jun 19, 2010·Journal of Immunological Methods·Jonas StankeAndreas M Kaufmann
Sep 22, 2010·PLoS Biology·Emily CorseJames P Allison
Apr 21, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Emily CorseJames P Allison
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Nov 3, 2011·Journal of Neuro-oncology·Derek R Johnson, Brian Patrick O'Neill
Nov 4, 2011·The New England Journal of Medicine·Antonio Di StasiMalcolm K Brenner
Jan 10, 2012·Proceedings of the National Academy of Sciences of the United States of America·Rachel A GottschalkJames P Allison
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Apr 27, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael HudecekStanley R Riddell
Aug 14, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Meenakshi HegdeNabil Ahmed
Dec 18, 2013·Science Translational Medicine·Victor D FedorovMichel Sadelain
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Dec 17, 2014·Clinical and Experimental Immunology·M P TanA K Sewell

❮ Previous
Next ❯

Citations

Jul 30, 2016·Oncoimmunology·Tiffany R HodgesAmy B Heimberger
Mar 22, 2016·Journal of Immunology Research·Yelei GuoWeidong Han
Dec 26, 2015·Trends in Pharmacological Sciences·Daniel T Harris, David M Kranz
Mar 11, 2016·Current Opinion in Immunology·Eugene A ZhukovskyMarcela V Maus
May 28, 2016·Molecular Therapy Oncolytics·Daniel Abate-Daga, Marco L Davila
May 27, 2016·CNS Oncology·Tiffany R HodgesAmy B Heimberger
Aug 23, 2016·Expert Review of Clinical Immunology·Andreas A Hombach, Hinrich Abken
May 11, 2016·Journal of Cellular Physiology·Albert T GacerezCharles L Sentman
Aug 24, 2016·Nature Reviews. Cancer·Andrew D FesnakBruce L Levine
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Melissa LeverOmer Dushek
Nov 12, 2016·Frontiers in Pharmacology·Tetsuro SasadaYuki Fujimoto
Dec 28, 2016·Cell Research·Laura A Johnson, Carl H June
Jan 29, 2016·Journal of the National Cancer Institute·Hanren DaiWeidong Han
Mar 28, 2017·Laboratory Investigation; a Journal of Technical Methods and Pathology·Robert SacksteinSteven R Barthel
May 10, 2017·Proceedings of the National Academy of Sciences of the United States of America·Udupi A RamagopalSteven C Almo
Jun 27, 2017·Cancer Letters·Ju YangBaorui Liu
Apr 14, 2016·Integrative Biology : Quantitative Biosciences From Nano to Macro·Deboki ChakravartiWilson W Wong
Jun 7, 2017·Expert Opinion on Biological Therapy·Robyn A A Oldham, Jeffrey A Medin
Dec 15, 2017·Journal of Immunotherapy·Gemma L OwensRichard Harrop
Mar 14, 2018·Expert Review of Anticancer Therapy·Brooke L PrinzingGiedre Krenciute
Dec 1, 2017·Current Opinion in Pediatrics·Liora M SchultzCrystal Mackall
Jan 21, 2017·Scientific Reports·Alexandre JuilleratLaurent Poirot
Feb 11, 2018·Archivum Immunologiae Et Therapiae Experimentalis·Zohreh Sadat Badieyan, Sayed Shahabuddin Hoseini
Oct 6, 2016·F1000Research·Preeti Sharma, David M Kranz
Dec 12, 2018·Annual Review of Immunology·Sonia GuedanCarl H June
Jul 30, 2019·Immunological Reviews·Zachary WalshM Eric Kohler
Jul 30, 2019·Immunological Reviews·David AkhavanChristine E Brown
Jan 18, 2020·International Journal of Molecular Sciences·Rebecca C AbbottMisty R Jenkins
Feb 7, 2020·Expert Opinion on Biological Therapy·Steven H ShenJohn H Sampson
Nov 15, 2016·Current Opinion in Pediatrics·Shannon L Maude
Mar 19, 2020·American Society of Clinical Oncology Educational Book·Martin J van den BentRanjit S Bindra
Feb 9, 2017·Oncotarget·Hans J Stauss
Jun 17, 2020·JCI Insight·Mauro CastellarinCarl H June
Aug 22, 2020·Expert Opinion on Investigational Drugs·Ying JiaoKongming Wu
Sep 11, 2019·Nature Medicine·Robbie G Majzner, Crystal L Mackall

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.